Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
PLOS ONE, 2021Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
Kerzeli I., Lord M., Doroszko M. et al.
Olink Target 96 Mouse
European Journal of Heart Failure, 2021Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction
Kresoja K., Rommel K., Wachter R. et al.
Olink Target 96
European Journal of Immunology, 2021Differential effects of estradiol and progesterone on human T cell activation in vitro
Papapavlou G., Hellberg S., Raffetseder J. et al.
Translational Psychiatry, 2021Toll-like receptor 4 methylation grade is linked to depressive symptom severity
Rasmusson A., Gallwitz M., Soltanabadi B. et al.
Journal of Extracellular Vesicles, 2021Extracellular vesicle‐mediated endothelial apoptosis and EV‐associated proteins correlate with COVID‐19 disease severity
Krishnamachary B., Cook C., Kumar A. et al.
Scientific Reports, 2021Statistical and machine learning methods for analysis of multiplex protein data from a novel proximity extension assay in patients with ST-elevation myocardial infarction
Maag E., Kulasingam A., Grove E. et al.
Nano Select, 2021Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia
Niemeyer B., Miller C., Ledesma‐Feliciano C. et al.
The American Journal of Clinical Nutrition, 2021Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic
Cauwenberghs N., Prunicki M., Sabovčik F. et al.
EP Europace, 2021Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies
De With R., Artola Arita V., Nguyen B. et al.
eClinicalMedicine, 2021Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial
Laursen J., Søndergaard-Heinrich N., de Melo J. et al.
F1000Research, 2021Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
Ren A., Prassas I., Sugumar V. et al.
Journal of Personalized Medicine, 2021Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
Guldvik I., Ekseth L., Kishan A. et al.
Allergy, 2021Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients
Mitamura Y., Schulz D., Oro S. et al.
ESC Heart Failure, 2021Identification of sex‐specific biomarkers predicting new‐onset heart failure
Raafs A., Verdonschot J., Ferreira J. et al.
Journal of Cachexia, Sarcopenia and Muscle, 2021Proteomic profiling of low muscle and high fat mass: a machine learning approach in the KORA S4/FF4 study
Huemer M., Bauer A., Petrera A. et al.
Clinical Chemistry and Laboratory Medicine (CCLM), 2021Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay
Fraser D., Chen M., Ren A. et al.
Nature Communications, 2021Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
Lacy M., Bürger C., Shami A. et al.
Journal of the American Society of Nephrology, 2021Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes
Satake E., Saulnier P., Kobayashi H. et al.
Journal of Allergy and Clinical Immunology, 2021Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications
Abyazi M., Bell K., Gyimesi G. et al.
Journal of the American Society of Nephrology, 2021Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
Matías-García P., Wilson R., Guo Q. et al.
4265 publications
Items per page
3601-3620 of 4265 publications